ArticleBMC nephrology2026

Nafamostat mesylate versus low-molecular-weight heparin during continuous renal replacement therapy in critically Ill adults: a single-center retrospective cohort study.

Xianguo Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.